...
首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >Overexpression of microRNA-375 impedes platelet-derived growth factor-induced proliferation and migration of human fetal airway smooth muscle cells by targeting Janus kinase 2
【24h】

Overexpression of microRNA-375 impedes platelet-derived growth factor-induced proliferation and migration of human fetal airway smooth muscle cells by targeting Janus kinase 2

机译:MicroRNA-375的过度表达通过靶向Janus激酶2阻碍血小板衍生的生长因子诱导的人胎儿气道平滑肌细胞的增殖和迁移

获取原文
获取原文并翻译 | 示例
           

摘要

The abnormal proliferation and migration of airway smooth muscle (ASM) cells play a critical role in airway remodeling during the development of asthma. MicroRNAs (miRNAs) have emerged as critical regulators of ASM cell proliferation and migration in airway remodeling. In this study, we aimed to investigate the potential role of miR-375 in the regulation of platelet-derived growth factor (PDGF)-induced fetal ASM cell proliferation and migration. Our results showed that miR-375 expression was significantly decreased in fetal ASM cells that were treated with PDGF. Functional data showed that overexpression of miR-375 inhibited the proliferation and migration of fetal ASM cells, whereas inhibition of miR-375 enhanced the proliferation and migration of fetal ASM cells. The results of bioinformatics analysis and a dual-luciferase reporter assay showed that miR-375 binds directly to the 3'-untranslated region of Janus kinase 2 (JAK2). Further data confirmed that miR-375 negatively regulates the expression of JAK2 in fetal ASM cells. Moreover, miR-375 also impeded the PDGF-induced activation of signal transducer and activator of transcription 3 (STAT3) in fetal ASM cells. However, restoration of JAK2 expression partially reversed the inhibitory effect of miR-375 on fetal ASM cell proliferation and migration. Overall, our results demonstrate that miR-375 inhibits fetal ASM cell proliferation and migration by targeting JAK2/STAT3 signaling. Our study provides a potential therapeutic target for the development of novel treatment strategies for pediatric asthma.
机译:气道平滑肌(ASM)细胞的异常增殖和迁移在哮喘发育过程中在气道重塑中发挥着关键作用。 MicroRNAS(miRNA)已成为ASM细胞增殖和迁移在气道重塑中的临界调节因素。在这项研究中,我们旨在探讨miR-375在血小板衍生的生长因子(PDGF)的调节中的潜在作用 - 诱导胎儿ASM细胞增殖和迁移。我们的研究结果表明,用PDGF处理的胎儿ASM细胞中miR-375表达显着降低。功能数据显示MIR-375的过表达抑制胎儿ASM细胞的增殖和迁移,而MiR-375的抑制增强了胎儿ASM细胞的增殖和迁移。生物信息学分析和双荧光素酶报告结果的结果表明miR-375直接与Janus激酶2(JAK2)的3'-未翻译的区域结合。进一步的数据证实,miR-375负调节胎儿ASM细胞中JAK2的表达。此外,MIR-375还阻碍了胎儿ASM细胞中的PDGF诱导的信号传感器和转录3(STAT3)活化剂的活化。然而,JAK2表达的恢复部分反转miR-375对胎儿ASM细胞增殖和迁移的抑制作用。总体而言,我们的结果表明MIR-375通过靶向JAK2 / Stat3信号来抑制胎儿ASM细胞增殖和迁移。我们的研究为开发小儿哮喘的新型治疗策略提供了潜在的治疗目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号